Media Coverage

2021

23/11/2021

Proteomics enters lucrative UK market for kidney test – The West Australian

23/11/2021

PromarkerD distribution network expands to Britain – Yahoo! Finance

05/11/2021

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline – Market Watch

03/11/2021

Proteomics (ASX:PIQ) awarded $100,000 project grant – The Market Herald

18/10/2021

Clinical study boosts Proteomics kidney test – The West Australian

12/08/2021

Proteomics International Laboratories (ASX:PIQ) contracts Biotem to manufacture test kits – The Market Herald

10/08/2021

Endometriosis Blood Test – ABC Radio

05/08/2021

Proteomics International to collaborate with University of Melbourne and Royal Women’s Hospital to develop a test for endometriosis – Proactive Investors

04/08/2021

Proteomics International to collaborate on world first blood test for endometriosis – The Sentiment

23/07/2021

6PR (Audio) – Proteomics: Predicting a disease before you get it – now that’s novel

22/07/2021

Proteomics International engages Abcam to manufacture PromarkerD reagents – Proactive Investors

16/07/2021

Proteomics International Laboratories (ASX:PIQ) shows diabetes drug improves PromarkerD risk scores – The Market Herald

28/06/2021

Vast US market opportunity seen for Proteomics kidney test – The West Australian

19/05/2021

Proteomics nails Avance testing contract – The West Australian

10/02/2021

PromarkerD: Predicting Diabetic Kidney Disease Before Symptoms Arrive – Medical Forum Magazine

Subscribe
  • This field is for validation purposes and should be left unchanged.